J0692 HCPCS code: Injection, cefepime hydrochloride, 500 mg
J0692 is the HCPCS Level II code for injection, cefepime hydrochloride, 500 mg. In 2024 Medicare paid an average of $0.99 per service for J0692 across 139,191 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 12 per day on DME suppliers. Medicare volume fell 22% from 2022 to 2024 (179,592 to 139,191 services). In 2024, about 776 clinicians billed Medicare for J0692 for 2,065 beneficiaries; Florida, Texas, Colorado accounted for 70% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2002-01-01 |
| Last action effective | 2002-01-01 |
Who bills J0692 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 776 |
| Medicare beneficiaries | 2,065 |
| States with claims | 29 |
| Share of services in top 3 states (Florida, Texas, Colorado) | 70% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0692, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 179,592 | 2,362 | $1.74 | $1.38 |
| 2023 | 151,786 | 2,233 | $1.23 | $0.98 |
| 2024 | 139,191 | 2,065 | $1.25 | $0.99 |
States with the most J0692 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 65,014 | $1.00 |
| Texas | 25,820 | $0.99 |
| Colorado | 5,884 | $1.01 |
| New Jersey | 4,906 | $0.99 |
| Georgia | 4,267 | $1.00 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 12 | Prescribing Information |
| outpatient hospital claims | 12 | Prescribing Information |
| practitioner claims | 12 | Prescribing Information |
What changed for J0692
- 2002-01-01: J0692 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0692?
J0692 is the HCPCS Level II code for injection, cefepime hydrochloride, 500 mg. Short descriptor: "Cefepime hcl for injection".
How much does Medicare pay for J0692?
In 2024, the average Medicare payment was $0.99 per service (average allowed $1.25).
Does Medicare cover J0692?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0692 can be billed per day?
12 on DME suppliers; 12 on outpatient hospital claims; 12 on practitioner claims (NCCI medically unlikely edits).
Related J06 codes
- J0600 — Injection, edetate calcium disodium, up to 1000 mg
- J0601 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0602 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
- J0603 — Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0604 — Cinacalcet, oral, 1 mg, (for esrd on dialysis)
- J0605 — Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
- J0606 — Injection, etelcalcetide, 0.1 mg
- J0607 — Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
- J0608 — Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
- J0609 — Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
- J0610 — Injection, calcium gluconate (fresenius kabi), per 10 ml
- J0611 — Injection, calcium gluconate (wg critical care), per 10 ml
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0692
- Watch J0692 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0692
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.